Incyte
INCY
#1064
Rank
C$32.23 B
Marketcap
C$161.37
Share price
5.78%
Change (1 day)
73.20%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of March 2026 : C$10.41 Billion

According to Incyte's latest financial reports the company's total assets are C$10.41 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$9.52 B21.97%
2024-12-31C$7.81 B-13.15%
2023-12-31C$8.99 B13.49%
2022-12-31C$7.92 B26.06%
2021-12-31C$6.28 B38.47%
2020-12-31C$4.54 B1.45%
2019-12-31C$4.47 B24.18%
2018-12-31C$3.60 B24.5%
2017-12-31C$2.89 B31.47%
2016-12-31C$2.20 B57.57%
2015-12-31C$1.39 B51.2%
2014-12-31C$0.92 B37.92%
2013-12-31C$0.67 B103.97%
2012-12-31C$0.32 B-1.81%
2011-12-31C$0.33 B-31.62%
2010-12-31C$0.48 B-34.71%
2009-12-31C$0.74 B165.28%
2008-12-31C$0.28 B2.74%
2007-12-31C$0.27 B-33.2%
2006-12-31C$0.41 B-5.48%
2005-12-31C$0.43 B-29.85%
2004-12-31C$0.62 B26.1%
2003-12-31C$0.49 B-43.54%
2002-12-31C$0.87 B-22.41%
2001-12-31C$1.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
C$168.15 B 1,515.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$294.53 B 2,728.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$165.38 B 1,488.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$131.23 B 1,160.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$2.17 B-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$0.80 B-92.23%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$0.15 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.14 B-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.71 B-93.13%๐Ÿ‡บ๐Ÿ‡ธ USA